国际妇产科学杂志 ›› 2019, Vol. 46 ›› Issue (2): 177-180.

• 综述 • 上一篇    下一篇

血小板参数及凝血功能相关指标预测子痫前期的研究进展

任丹玉,王永红   

  1. 030001 太原,山西医科大学第二临床医学院
  • 收稿日期:2018-12-03 修回日期:2019-01-10 出版日期:2019-04-15 发布日期:2019-04-15
  • 通讯作者: 王永红,E-mail:wangyh19672000@126.com E-mail:515891691@qq.com
  • 基金资助:
    山西省重点研发计划(指南)项目(201603D321038);山西医科大学校级博士启动基金项目(BS201713)

Progress Research of Platelet Parameters and Coagulation Function Related Indicators on Prediction of Pre-Eclampsia

REN Dan-yu,WANG Yong-hong   

  1. Second Clinical Medical College of Shanxi Medical University,Taiyuan 030001,China
  • Received:2018-12-03 Revised:2019-01-10 Published:2019-04-15 Online:2019-04-15
  • Contact: WANG Yong-hong,E-mail:wangyh19672000@126.com E-mail:515891691@qq.com

摘要: 子痫前期是导致孕产妇及围生儿死亡的主要妊娠期特发性疾病。近年来,随着早产儿救治水平的提高,妊娠34周后子痫前期的积极治疗会获得良好母儿结局,但早发型子痫前期患者的治疗仍然差强人意,因此预测子痫前期的发生成为研究热点。研究发现子痫前期的发病与凝血-纤溶系统失衡有关。其中血小板参数、凝血四项、纤溶酶原激活物抑制剂1(PAI-1)、血管性血友病因子(vWF)、P-选择素和D-二聚体对子痫前期具有预测价值。综述这些指标用于预测子痫前期的研究进展。

关键词: 先兆子痫, 血小板计数, 纤溶酶原激活物抑制物1, P选择素, 预测

Abstract: Pre-eclampsia (PE) is the main pregnancy-specific disease that causes maternal and perinatal death. In recent years, with the improvement of the level of treatment of premature infants, the active treatment of pre-eclampsia after 34 weeks of gestation will get good maternal and perinatal outcomes, but the treatment of early-onset pre-eclampsia patients is still unsatisfactory, so the prediction of pre-eclampsia has become a research hot spot. Studies found that pre-eclampsia is associated with the imbalance of coagulation-fibrinolysis system. In many researches, some factors are used to predict pre-eclampsia, for instance, platelet parameters, coagulation quadruple, PAI-1, vWF, P-selectin, and D-dimer. This article reviews the progress of these indicators to predict pre-eclampsia.

Key words: Pre-eclampsia, Platelet count, Plasminogen activator inhibitor 1, P-selectin, Forecasting